However, NP-T1 was not associated with BMI in the cLBP group ( p = 0.19, age-adjusted), suggesting that incorporating BMI data would not alter the overall study conclusions
BPC-157 in research: molecular mechanisms, protocols and the 2026 state of science Why BPC-157 generates such scientific curiosity BPC-157 (Body Protection Compound-157) is a fifteen-amino acid peptide that occupies an unusual position in the contemporary biomedical research landscape: abundantly studied in animal literature for thirty years, practically absent from human clinical studies, and yet one of the most discussed "research peptides" in 2026
You want to see how you respond to incretin-based therapy before committing to the more expensive option
Use immediately for best results
No human clinical trials have established BPC-157 timelines for any condition
To be considered, requests for NTIOL reviews must include information requested on the CMS website at: